| Name | (1S,3R,5Z,7E,23S)-1,3-Dihydroxy-23,26-epoxy-9,10-secocholesta-5,7 ,10,25(27)-tetraen-26-one | 
|---|
| Description | TEI-9647 is a first and potent VDR/vitamin D-responsive element (DRE)-mediated genomic actions antagonist. TEI-9647 is a 1α,25-dihydroxyvitamin D3-26,23-lactone (1α,25-lactone) analogue[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 VDR[1]  | 
                        
| In Vitro | TEI-9647 (100 nM; 24 hours; HL-60 cells) treatment clearly suppresses p21WAF1,CIP1 gene expression induced by 1α,25(OH)2D3[1]. TEI-9647 blocks both 1α,25(OH)2D3-mediated HL-60 cell differentiation and also activation of the luciferase reporter in COS-7 cells that has been transfected with the cDNA containing the DRE of the rat 25(OH)D3-24-hydroxylase gene and cDNA of the human vitamin D nuclear receptor[1]. RT-PCR[1] Cell Line: HL-60 cells Concentration: 100 nM Incubation Time: 24 hours Result: Clearly suppressed p21WAF1,CIP1 gene expression induced by 1α,25(OH)2D3. | 
| References | 
| Boiling Point | 618.492ºC at 760 mmHg | 
|---|---|
| Molecular Formula | C27H38O4 | 
| Molecular Weight | 426.58800 | 
| Flash Point | 204.543ºC | 
| Exact Mass | 426.27700 | 
| PSA | 66.76000 | 
| LogP | 5.02530 | 
| Vapour Pressure | 0mmHg at 25°C | 
| Index of Refraction | 1.567 |